Cencora, Inc. (COR)

The company now

Cencora reported fiscal fourth-quarter 2026 revenue of $88.4 billion on 4 November 2026, up 5.5 percent, and fiscal 2026 revenue of $337.4 billion, up 5.0 percent 1.

The company's adjusted (non-GAAP) diluted earnings per share for the year were $17.97, up 12.3 percent 1. Chief executive Robert P Mauch called fiscal 2026 a year in which Cencora expanded its MSO platform through the OneOncology acquisition 1.

An MSO, or management services organization, handles business support for independent physician practices, and Cencora's retina and oncology platforms are built this way 910.

Starting in the first quarter of fiscal 2027 the company will report two segments, Pharmaceutical Distribution and Services and Specialty Pharmaceutical and Provider Services, plus an Other group 2.

On 21 October 2026 Cencora announced an agreement to buy American Oncology Network, a physician-led network of more than 350 oncology providers across 21 states, at an enterprise value of $2.4 billion 6.

That deal needs regulatory clearances and AON stockholder approval 6. Separately, the Federal Trade Commission asked for more information on 20 May 2026 about the planned merger of MWI Animal Health with Covetrus, which the company assumes will close on 31 March 2027 51.

As of Nov 4, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.